Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
0.940
-0.019 (-1.98%)
At close: Sep 6, 2024, 4:00 PM
0.962
+0.022 (2.36%)
After-hours: Sep 6, 2024, 7:51 PM EDT
Precigen Market Cap
Precigen has a market cap or net worth of $270.77 million as of September 6, 2024. Its market cap has decreased by -33.34% in one year.
Market Cap
270.77M
Enterprise Value
257.58M
1-Year Change
-33.34%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $270.77M, a decrease of -88.33%. That is a compound annual growth rate of -17.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2024 | 242.40M | -27.34% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enGene Holdings | 291.94M |
| Editas Medicine | 287.83M |
| Cartesian Therapeutics | 287.81M |
| Prelude Therapeutics | 285.03M |
| Tectonic Therapeutic | 282.46M |
| Biomea Fusion | 277.01M |
| Inogen | 274.90M |
| ProKidney | 274.79M |